US: (888) 231-0816

USDM Life Sciences Collaborates with Oracle Health Sciences

USDM Life Sciences Collaborates with Oracle Health Sciences to Drive Transformation and Innovation in Compliance and Technology

SANTA BARBARA, CALIFORNIA — (October 6, 2020) — USDM Life Sciences, a leading global technology consulting firm focused on increasing the capacity of life sciences organizations to accelerate innovation and maximize productivity, is collaborating with Oracle Health Sciences, a leader in eClinical software, to provide world-class solutions that enable global life sciences companies to meet FDA 21 CFR Part 11 regulatory requirements. Now, USDM Cloud Assurance™ subscription service supports Oracle Health Sciences’ Clinical One™ platform helping ensure critical continuous cloud regulatory compliance.

“Oracle Clinical One is changing how technology supports clinical research to improve efficiency and help bring breakthrough therapies to market faster,” said Drew Zwiebel, global vice president alliances & channels, Oracle Health Sciences. “USDM Life Sciences has a long history of working with both Oracle and life sciences customers. Based on their expertise and experience, the USDM Cloud Assurance subscription service is an obvious choice to aid Oracle Clinical One customers in meeting their complex compliance needs.”

Oracle Clinical One is a truly unified eClinical platform that harmonizes data, streamlines workflow, and saves significant time from study startup to study closeout. Oracle Health Sciences was recently named a “Leader” in the Everest Group Clinical Development Platforms Products PEAK Matrix® for the fourth straight year and was noted for offering the closest to an end-to-end platform in the current clinical development platform landscape with Clinical One.

“Cloud Assurance helps customers quickly adopt Oracle Clinical One and benefit from its features and capabilities,” said John Petrakis, vice president of cloud assurance at USDM. “They can rest assured that Oracle Clinical One will be continuously compliant with every new release. Best of all, the customers’ time and cost in managing compliance are decreased so they can focus on value-generating IT activities.”

About USDM Cloud Assurance™
USDM Cloud Assurance™ subscription service provides an innovative approach for maintaining GxP compliance in the cloud. Life sciences organizations can trust that their cloud technology is implemented, validated, and maintained in a compliant state while saving significant time and money. More importantly, you can allocate your internal IT resources to higher-value-generating priorities and leave the burden of compliance to USDM.

Webinar to Learn More
Please join our upcoming webinar to understand how you can advance your clinical trial technology environment and achieve continuous GxP compliance with USDM Cloud Assurance and Oracle Clinical One.

Oracle Clinical One: Next Generation Clinical Trials with Continuous GxP Compliance
Thursday, October 29, 11 am PDT | 2 pm EDT

Watch On-Demand

About USDM Life Sciences
USDM Life Sciences provides strategy and compliant technology solutions to regulated life sciences companies and makes it easy to accelerate transformation and innovation. USDM focuses exclusively on the regulated biotechnology, pharmaceutical, and medical device industries and is a compliance partner with the world’s top technology software developers. For more information, visit

About Oracle Health Sciences
As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years’ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. Learn more about Oracle Health Sciences.

Oracle and Java are registered trademarks of Oracle and/or its affiliates.

Want to talk with our
subject matter experts?